Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 2/20 | 0.57 |
| ▸ | SELL | P14151 | 1/20 | 0.57 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.49 |
| ▸ | MAG | P20916 | 6/20 | 0.47 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.42 |
| ▸ | SELE | P16581 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27421227 | 0.89 | SELP (0.45) | SELPSELLSIGLEC7MAGNANP | |
| SCHEMBL19820225 | 0.85 | MAG (0.53) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL25124346 | 0.85 | MAG (0.53) | SELPSELLSIGLEC7MAG | |
| SCHEMBL21153675 | 0.83 | SIGLEC7 (0.52) | SELPSELLSIGLEC7MAGNANP | |
| SCHEMBL14750348 | 0.81 | SELL (0.53) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL18732825 | 0.79 | SELL (0.60) | SELPSELLSIGLEC7MAGNANP | |
| SCHEMBL13449385 | 0.79 | SELL (0.60) | SELPSELLSIGLEC7MAGNANP | |
| SCHEMBL13147729 | 0.79 | SELL (0.68) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL29432543 | 0.78 | SELP (0.65) | SELPSELLSIGLEC7MAGNANP | |
| SCHEMBL17722601 | 0.78 | MAG (0.48) | SELPSELLSIGLEC7MAGNANP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230098432-A1 | SYNTHESIS OF GLYCOSYL FLUORIDES | CARBOCODE S A (PT) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098432-A1 | SYNTHESIS OF GLYCOSYL FLUORIDES | MAN2B1, GBA1, FUCA1 | SELP 2274/4885SELL 2854/4885SIGLEC7 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.